Mirae Asset Capital Life Science

Mirae Asset Capital Life Science was formed in 2023 as a joint venture between Mirae Asset Capital. See sector focus, stage focus and contact routes.

About Mirae Asset Capital Life Science

Mirae Asset Capital Life Science was formed in 2023 as a joint venture between Mirae Asset Capital and Mirae Asset Global Investments. It is dedicated to investing in life science, with a differentiated investment strategy rooted in drug development, clinical data, and market dynamics. The firm invests in companies prioritizing the delivery of safe and effective treatments to patients.

Mirae Asset Capital Life Science at a glance

Location
Boston, MA, USA
Investor type
Venture Capital
Stages
Pre Seed, Seed, Series A

Frequently asked about Mirae Asset Capital Life Science

What does Mirae Asset Capital Life Science invest in?
Mirae Asset Capital Life Science (Boston, MA, USA) — sector focus: Biotech, Healthcare; stage focus: Pre Seed, Seed, Series A.
How do I contact Mirae Asset Capital Life Science?
Mirae Asset Capital Life Science's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Mirae Asset Capital Life Science headquartered?
Mirae Asset Capital Life Science is based in Boston, MA, USA.

Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.

Investors similar to Mirae Asset Capital Life Science (40)

Browse related investor lists (9)

Compare Mirae Asset Capital Life Science (8)

Investors like Mirae Asset Capital Life Science · Full investor directory · Investor access · Company funding database